Galapagos’ shareholders approve all resolutions proposed by the Board of Directors at the annual shareholders’ meeting
25 Avril 2023 - 10:01PM
Mechelen, Belgium;
25 April
2023, 22.01
CET; Galapagos NV (Euronext & NASDAQ:
GLPG) today announces
the approval of all resolutions proposed
at its annual shareholders’ meeting
(AGM) held today at 14.00
CET.
The AGM approved, amongst other items,
- the re-appointments of Mr. Peter
Guenter as non-executive independent director for a period of 4
years, and of Mr. Daniel O’Day and Dr. Linda Higgins as
non-executive non-independent directors for a period of 4 years,
all effective as of today
- the appointment of BDO
Bedrijfsrevisoren BV, permanently represented by Ms. Ellen
Lombaerts, as new statutory auditor of Galapagos for a period of 3
years
All documents related to the AGM can be
consulted on the Galapagos website.
About
GalapagosGalapagos is a fully integrated biotechnology
company focused on discovering, developing, and commercializing
innovative medicines. We are committed to improving patients’ lives
worldwide by targeting diseases with high unmet needs. Our R&D
capabilities cover multiple drug modalities, including small
molecules and cell therapies. Our portfolio comprises discovery
through to commercialized programs in immunology, oncology, and
other indications. Our first medicine for rheumatoid arthritis and
ulcerative colitis is available in Europe and Japan. For additional
information, please visit www.glpg.com or follow us
on LinkedIn or Twitter.
Contacts
| Media
relations |
Investor
relations |
| Marieke
Vermeersch |
Sofie Van
Gijsel |
| +32 479
490 603 |
+1 781 296
1143 |
| |
|
| Elisa
Chenailler |
Sandra
Cauwenberghs |
| +41 79 853 33
54 |
+32 495 58 46
63 |
| |
ir@glpg.com |
| Hélène de
Kruijs |
|
| +31 6
22463921 |
|
|
media@glpg.com |
|
Forward-looking statements
This release may contain forward-looking
statements. Such forward-looking statements are not guarantees of
future results. These forward-looking statements speak only as of
the date of publication of this release. We expressly disclaim any
obligation to update any forward-looking statements in this
release, unless specifically required by law or regulation.
- Galapagos’ shareholders approve all resolutions proposed by the
Board of Directors at the annual shareholders’ meeting
Galapagos (EU:GLPG)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Galapagos (EU:GLPG)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024
